MG
ELOX

Michael Gelband’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Michael Gelband’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-493
Closed -$32K – 2762
2021
Q3 		$32K Buy
+493
New +$30.4K ﹤0.01% 1999

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 374.31% 1-Year Est. Return

Michael Gelband's ELOX Position: Q4 2021 in Review

Michael Gelband sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2021, closing a stake of 493 shares — an estimated $32K sold.

Michael Gelband first reported a position in ELOX in Q3 2021 and held it in 1 quarter. The position peaked at $32K in Q3 2021. 38 funds tracked by Wall St. Rank hold ELOX as of Q4 2021.

  • Michael Gelband reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Michael Gelband sold 493 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $32K.
  • Michael Gelband first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Michael Gelband's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $32K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.